| 2023-02 | Discovery of dioxo-benzo[b]thiophene derivatives as potent YAP-TEAD interaction inhibitors for treating breast cancer | Son, Youngchai; Kim Jaeyeal; Kim, Yongchan; Chi, Sung-Gil; Kim, Tackhoon; Yu, Jinha |
| 2023-02 | Efficient prioritization of CRISPR screen hits by accounting for targeting efficiency of guide RNA | Park, Byung-Sun; Jeon, Heeju; Chi, Sung-Gil; Kim, Tackhoon |
| 2025-07 | Perturbomics: CRISPR-Cas screening-based functional genomics approach for drug target discovery | Park, Byung-Sun; Lee, Mieun; Kim, Jaeyeol; Kim, Tackhoon |
| 2024-07 | Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma | Park, Byung-Sun; Jeon, Heeju; Kim, Yeonseo; Kwon, Haejin; Choi, Ga-Eun; Chi, Sung-Gil; Park, Hyun-Mee; Lee, Hyunbeom; Kim, Tackhoon |
| 2021-05 | Scalable recombinase-based gene expression cascades | Kim, Tackhoon; Weinberg, Benjamin; Wong, Wilson; Lu, Timothy K. |
| 2026-01 | Synthetic essentiality of isoprenylcysteine carboxylmethyltransferase in PTEN deficient triple negative breast cancer | Park, Byung-Sun; Kim, Jaeyeol; Seo, Dong-Chan; Choi, Ga-Eun; Seo, Jin-Ju; Lee, Seung Eun; Kim, Tackhoon |
